TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39)

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250082730A1
SERIAL NO

18745091

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods for treating hyperinsulinemic hypoglycemia, such as hyperinsulinemic hypoglycemia after bariatric surgery, are provided. In some embodiments, an effective amount of the glucagon-like peptide-1 receptor antagonist exendin(9-39) is subcutaneously administered twice per day.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYOFFICE OF THE GENERAL COUNSEL BUILDING 170 3RD FLOOR MAIN QUAD P O BOX 20386 STANFORD CA 94305

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CRAIG, Colleen M Stanford, US 13 55
MCLAUGHLIN, Tracey L Stanford, US 12 55

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation